Skip to main content
Clinical Trials/NCT07595757
NCT07595757Active, not recruitingPhase 1

Clinical Evaluation of Nano-Hyaluronic Acid as an Adjunctive to Minimally Invasive Non-Surgical Technique in the Treatment of Deep Intrabony Defects: Randomized Controlled Clinical Trial

Cairo University1 site in 1 country28 target enrollmentStarted: July 15, 2025Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
28
Locations
1

Study Overview

Brief Summary

This randomized controlled clinical trial aims to evaluate the effectiveness of using nano-hyaluronic acid (nano-HyA) gel alongside a minimally invasive non-surgical technique (MINST) to treat deep intrabony defects in patients with Stage II and III periodontitis. While MINST is a proven method for cleaning deep periodontal pockets without the need for traditional surgery , the addition of nano-HyA may further enhance soft tissue healing, reduce inflammation, and promote regeneration. Participants in the study will be randomly assigned to one of two groups. The test group will receive the MINST procedure combined with the application of nano-HyA gel into the periodontal pocket, while the control group will receive the MINST procedure alone. The primary goal of the study is to measure the decrease in probing pocket depth over a 6-month follow-up period to determine if the adjunctive use of nano-HyA provides superior clinical and radiographic outcomes compared to non-surgical treatment alone

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Males and females aged ≥ 18 years.
  • Patients with a diagnosis of periodontitis (stage II or III).
  • At least one tooth with ≥5 mm PPD and CAL and evidence of radiographic bone loss.
  • Presenting with at least 1 intrabony defect, with a radiographic intra-bony component ≥3 mm.

Exclusion Criteria

  • Patients with systemic diseases.
  • Pregnant or lactating females.
  • Tobacco smokers (≥ 10 cigarettes per day).
  • Multi-rooted teeth with class II and class III furcation defects.
  • Third molars.
  • Teeth with grade III mobility.
  • Peri-apical pathology and acute abscess.
  • Non-surgical or surgical periodontal treatment in the past 12 months.
  • Prolonged treatment with antibiotics or anti-inflammatory agents within 6 months before periodontal therapy.

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mustafa Hussein Alshebli

Master's student, Periodontology

Cairo University

Study Sites (1)

Loading locations...

Similar Trials